Benzinga's Top #PreMarket Gainers

By: via Benzinga
Amicus Therapeutics (NASDAQ: FOLD) shares gained 11.68% to $3.73 in pre-market trading after jumping 10.23% on Monday. Salix ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.